What is the optimal serum ferritin range for a healthy adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Optimal Ferritin Range for Healthy Adults

For healthy adults, the optimal serum ferritin range is ≥30 ng/mL for general adults (excluding menstruating/pregnant individuals), ≥30 ng/mL for menstruating individuals, and ≥30 ng/mL for pregnant individuals, based on the most recent 2026 American Society of Hematology guidelines that prioritize detecting iron deficiency before it impacts quality of life. 1

Population-Specific Thresholds

Non-Menstruating, Non-Pregnant Adults

  • Lower threshold for iron deficiency diagnosis: ≤30 ng/mL 1
  • For adults with symptoms (fatigue, decreased cognition, restless legs, pica, decreased exercise tolerance) or risk factors (heavy bleeding, inflammatory bowel disease, bariatric surgery, vegetarian diet, chronic PPI use), use ≤50 ng/mL as the diagnostic threshold 1
  • This represents a significant shift from older WHO cutoffs of ≤15 ng/mL, which missed 59% of true iron deficiency cases (sensitivity only 0.41) 1

Menstruating Individuals

  • Lower threshold: ≤30 ng/mL 1
  • For those with heavy menstrual bleeding, abnormal uterine bleeding, symptoms, upcoming surgery, or planning pregnancy: ≤50 ng/mL 1
  • The 27% global prevalence of iron deficiency in this population justifies the higher threshold 1

Pregnant Individuals

  • Lower threshold: ≤30 ng/mL (conditional recommendation) 1
  • Strong recommendation against using ≤15 ng/mL 1
  • For pregnant individuals with anemia or other risk factors (teenage pregnancy, hyperemesis, multiple gestation, short interpregnancy interval <18 months): consider ≤50 ng/mL 1

Children

  • Ages 9 months to 4 years: ≤20 ng/mL 1
  • Ages >4 years to adolescence: ≤20 ng/mL (by indirect evidence) 1
  • Non-menstruating adolescents: ≤30 ng/mL 1
  • Menstruating adolescents: follow adult menstruating guidelines 1

Special Populations

Adults with Inflammation

  • Cannot rely on ferritin alone 1
  • Use both ferritin AND transferrin saturation (TSAT) 1
  • Diagnose iron deficiency when:
    • TSAT <20% (fasting sample, 5-9 hours without food/supplements), OR
    • Ferritin <100 ng/mL 1
  • Applies to inflammatory bowel disease, cancer, chronic kidney disease, heart failure, rheumatologic disorders 1

Cancer Patients

  • Higher cutoff of <100 ng/mL for absolute iron deficiency 2

Clinical Reasoning Behind These Thresholds

The 2026 ASH guidelines represent a paradigm shift based on diagnostic accuracy data showing:

  • At ≤15 ng/mL: sensitivity 0.41, specificity 0.99 (misses most cases)
  • At ≤30 ng/mL: sensitivity 0.67, specificity 0.96 (balanced approach)
  • At ≤50 ng/mL: sensitivity 0.89, specificity 0.86 (catches nearly all cases) 1

The panel prioritized not missing iron deficiency over false positives, given that untreated iron deficiency causes fatigue, impaired cognition, decreased physical performance, restless legs syndrome, and reduced quality of life—even without anemia 1. The benefits of identifying and treating iron deficiency (improved symptoms, quality of life, physical performance) outweigh the minimal harms of iron supplementation in false positives 1.

Critical Pitfalls to Avoid

  1. Inflammation falsely elevates ferritin: Always check C-reactive protein when ferritin seems normal but clinical suspicion remains high 2. Ferritin is an acute phase reactant and can be normal or elevated despite true iron deficiency in inflammatory states 1

  2. Don't use hemoglobin alone: Multiple guidelines recommend against using hemoglobin or hematocrit alone to evaluate for iron deficiency 2. Iron deficiency causes significant morbidity before anemia develops

  3. Age and sex matter: Ferritin naturally increases with age in women (especially after menopause) and is consistently higher in men 1, 3, 4. A 25-year-old menstruating woman and a 65-year-old man require different interpretations

  4. Laboratory reference ranges are outdated: Most commercial assays report lower limits of 9-23 μg/L, which are based on flawed studies that didn't exclude iron-deficient individuals from "healthy" reference populations 5. These ranges contribute to systematic underdiagnosis

Practical Algorithm

Step 1: Measure serum ferritin

  • If <30 ng/mL (or <20 ng/mL in young children): diagnose iron deficiency
  • If 30-50 ng/mL with symptoms or risk factors: diagnose iron deficiency
  • If >50 ng/mL without inflammation: iron deficiency unlikely

Step 2: If inflammation suspected (IBD, cancer, CKD, heart failure, rheumatologic disease):

  • Add TSAT (fasting)
  • Diagnose iron deficiency if TSAT <20% OR ferritin <100 ng/mL

Step 3: For menstruating individuals with heavy bleeding or pregnant individuals with anemia:

  • Use 50 ng/mL threshold regardless of symptoms

The 2025 Lancet Haematology consensus further supports ferritin <50 ng/mL as a reasonable starting point for adults, though acknowledging the appropriate cutoff cannot be definitively established from current evidence 2. However, the 2026 ASH guidelines provide the most rigorous, evidence-based approach using diagnostic test accuracy data against bone marrow examination as the reference standard 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.